Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease

Gastroenterology. 2019 Jun;156(8):2158-2173. doi: 10.1053/j.gastro.2019.02.036. Epub 2019 Mar 1.

Abstract

Acidification of the gastric lumen poses a barrier to transit of potentially pathogenic bacteria and enables activation of pepsin to complement nutrient proteolysis initiated by salivary proteases. Histamine-induced activation of the PKA signaling pathway in gastric corpus parietal cells causes insertion of proton pumps into their apical plasma membranes. Parietal cell secretion and homeostasis are regulated by signaling pathways that control cytoskeletal changes required for apical membrane remodeling and organelle and proton pump activities. Helicobacter pylori colonization of human gastric mucosa affects gastric epithelial cell plasticity and homeostasis, promoting epithelial progression to neoplasia. By intervening in proton pump expression, H pylori regulates the abundance and diversity of microbiota that populate the intestinal lumen. We review stimulation-secretion coupling and renewal mechanisms in parietal cells and the mechanisms by which H pylori toxins and effectors alter cell secretory pathways (constitutive and regulated) and organelles to establish and maintain their inter- and intracellular niches. Studies of bacterial toxins and their effector proteins have provided insights into parietal cell physiology and the mechanisms by which pathogens gain control of cell activities, increasing our understanding of gastrointestinal physiology, microbial infectious disease, and immunology.

Keywords: Acid Secretion; Bacteria; Gastric Organoids; H pylori; Syntelin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Female
  • Gastric Mucosa / microbiology
  • Gastric Mucosa / pathology
  • Gastrointestinal Microbiome / drug effects*
  • Gastrointestinal Microbiome / physiology
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / pathology*
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Male
  • Parietal Cells, Gastric / pathology*
  • Precancerous Conditions / drug therapy
  • Precancerous Conditions / pathology*
  • Prognosis
  • Risk Assessment
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / pathology*
  • Stomach Neoplasms / surgery
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents